Cargando…
Efficacy and safety of compassionate use for rare diseases: a scoping review from 1991 to 2022
BACKGROUND: Compassionate use is a system that provides patients with expedited access to drugs which has not yet been approved, but currently in clinical trials. The investigational drugs have been authorized for compassionate use in cases involving patients suffered from life-threatening diseases...
Autores principales: | Wu, Jiayu, Yang, Yang, Yu, Jiaxin, Qiao, Luyao, Zuo, Wei, Zhang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685565/ https://www.ncbi.nlm.nih.gov/pubmed/38017575 http://dx.doi.org/10.1186/s13023-023-02978-x |
Ejemplares similares
-
Status of Compassionate, Respectful, and Caring Health Service Delivery: Scoping Review
por: Nigusie, Adane, et al.
Publicado: (2022) -
How compassionate communities are implemented and evaluated in practice: a scoping review
por: Dumont, Katia, et al.
Publicado: (2022) -
Ceftazidime-Avibactam for Carbapenem-Resistant Gram-Negative Bacteria Infections: A Real-World Experience in the ICU
por: Yu, Jiaxin, et al.
Publicado: (2023) -
The Role of Compassionate Technology in Blended and Digital Mental Health Interventions: Systematic Scoping Review
por: van Lotringen, Charlotte, et al.
Publicado: (2023) -
Compassionate use programmes for rare diseases: proposals for actions
por: Houÿez, François, et al.
Publicado: (2012)